A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
NCT01345201
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
BIOLOGICAL:
OMP-18R5
Sponsor
OncoMed Pharmaceuticals, Inc.